Population trends in antihypertensive drug use: Results from the MONICA Augsburg Project 1984 to 1995

Journal of Clinical Epidemiology

Volumn 52, Issue 7, 1999, Pages 695-703

  Gasse, Christiane ^a   Stieber, Jutta ^b   Döring, Angela ^b   Keil, Ulrich ^a   Hense, Hans Werner ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Antihypertensive treatment; Hypertension; Population based study; Trend

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RESERPINE;

ADULT; ARTICLE; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MALE; PHARMACOEPIDEMIOLOGY; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL;

ADULT; ANTIHYPERTENSIVE AGENTS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GERMANY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PREVALENCE;

EID: 0033051470     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(99)00035-9     Document Type: Article

References (40)

1. Deutsche Liga zur Bekämpfung des Hohen Blutdruckes Empfehlungen zur Hochdruckbehandlung in der Praxis und zur Behandlung hypertensiver Notfälle. 1984;Deutsche Liga zur Bekämpfung des Hohen Blutdruckes, Heidelberg.
2. Deutsche Liga zur Bekämpfung des Hohen Blutdruckes Empfehlungen zur Hochdruckbehandlung in der Praxis und zur Behandlung hypertensiver Notfälle. 1988;Deutsche Liga zur Bekämpfung des Hohen Blutdruckes, Heidelberg.
3. Deutsche Liga zur Bekämpfung des Hohen Blutdruckes Empfehlungen zur Hochdruckbehandlung in der Praxis und zur Behandlung hypertensiver Notfälle. 1990;Deutsche Liga zur Bekämpfung des Hohen Blutdruckes, Heidelberg.
4. Deutsche Liga zur Bekämpfung des Hohen Blutdruckes Empfehlungen zur Hochdruckbehandlung in der Praxis und zur Behandlung hypertensiver Notfälle. 1994;Deutsche Liga zur Bekämpfung des Hohen Blutdruckes, Heidelberg.
5. Zanchetti A. Guidelines for the management of hypertension. The World Health Organization/International Society of Hypertension view. World Health Organization. International Society of Hypertension J Hypertens. 13(Suppl):1995;S119-S122.
6. Sever P., Beevers G., Bulpitt C., Lever A., Ramsay L., Reid J.et al. Management guidelines in essential hypertension. Report of the second working party of the British Hypertension Society BMJ. 306:1993;983-987.
7. Ogilvie RI, Burgess ED, Cusson JR, Feldman RD, Leiter LA, Myers MG. Report of the Canadian Hypertension Society Consensus Conference: 3 Pharmacologic treatment of essential hypertension. Can Med Assoc J 1993; 149: 575-584.
8. Jackson R., Barham P., Bills J., Birch T., McLennan L., MacMahon S.et al. Management of raised blood pressure in New Zealand. A discussion document BMJ. 307:1993;107-110.
9. The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984; 144: 1045-1057.
10. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988; 148: 1023-1038.
11. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
12. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure A cooperative study. JAMA. 237:1977;255-261.
13. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
14. Trye P., Jackson R., Yee R.L., Beaglehole R. Trends in the use of blood pressure lowering medications in Auckland, and associated costs, 1982-94. N Z Med J. 109:1996;270-272.
15. Manolio T.A., Cutler J.A., Furberg C.D., Psaty B.M., Whelton P.K., Applegate W.B. Trends in pharmacologic management of hypertension in the United States [see comments]. Arch Intern Med. 155:1995;829-837.
16. Whelton P.K., Brancati F.L. Hypertension management in populations. Clin Exp Hypertens. 15:1993;1147-1156.
17. Epstein M., Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med. 156:1996;1969-1978.
18. Sica D.A. Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy? Drugs. 48:1994;16-24.
19. Hense H.W., Tennis P. Changing patterns of antihypertensive drug use in a German population. Eur J Clin Pharmacol. 39:1990;1-7.
20. Oster J.R., Epstein M. Fixed-dose combination medications for the treatment of hypertension. A critical review J Clin Hypertens. 3:1987;278-293.
21. WHO MONICA Project Principal Investigators The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease). A major international collaboration. WHO MONICA Project Principle Investigators J Clin Epidemiol. 41:1988;105-114.
22. Hense H.W., Koivisto A.M., Kuulasmaa K., Zaborskis A., Kupsc W., Tuomilehto J. Assessment of blood pressure measurement quality in the baseline surveys of the WHO MONICA project. J Hum Hypertens. 9:1995;935-946.
23. Deutsche Liga zur Bekämpfung des Hohen Blutdruckes. Empfehlungen zur Behandlung von Patienten mit milder Hypertonie. Heidelberg: Deutsche Liga zur Bekämpfung des Hohen Blutdruckes: 1991.
24. Burt V.L., Cutler J.A., Higgins M., Horan M.J., Labarthe D., Whelton P.et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 26:1995;60-69.
25. Lewis M., Lowel H., Stieber J., Engelbrecht R., Hormann A., John J. Drug interactions in the prescriptions of patients before and after a heart infarct. Results of the MONICA Augsburg heart infarct registry Soz Praeventivmed. 36:1991;9-17.
26. van Leer E.M., Seidell J.C., Kromhout D. Levels and trends in blood pressure and prevalence and treatment of hypertension in The Netherlands, 1987-1991. Am J Prev Med. 10:1994;194-199.
27. Meyer D. Analyse de Arzneimittelverbrauchs in Bremen 1984 und 1989. 1994;Peter Lang, Frankfurt, Berlin, New York.
28. Hoffmeister H., Mensink G.B., Stolzenberg H., Hoeltz J., Kreuter H., Laaser U.et al. Reduction of coronary heart disease risk factors in the German cardiovascular prevention study. Prev Med. 25:1996;135-145.
29. Hense H.W., Stieber J., Filipiak B., Keil U. Five-year changes in population blood pressure and hypertension prevalence. Results from the MONICA Augsburg surveys 1984/85 and 1989/90. Ann Epidemiol. 3:1993;410-416.
30. Flack J.M., Cushman W.C., Kvasnicka J., Grimm R.H., Neaton J.D., Grimm R.H. Jr. et al. Evidence for the efficacy of low-dose diuretic monotherapy treatment of hypertension in the presence of coexisting medical conditions. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. Am J Med. 270:1993;713-724.
31. Maisch B., Brilla C., Kruse T. Directions in antihypertensive treatment - our future from the past. Eur Heart J. 16(Suppl C):1995;74-83.
32. Medical Research Council Working Party MRC trial of treatment of mild hypertension. Principal results. Medical Research Council Working Party BMJ. 291:1985;97-104.
33. Zanchetti A., Chalmers J.P., Arakawa K., Gyarfas I., Hamet P., Hansson L.et al. The 1993 guidelines for the management of mild hypertension. Memorandum from a WHO/ISH meeting Blood Pressure. 2:1993;86-100.
34. Wallenius S., Peura S., Klaukka T., Enlund H. Who is using antihypertensive drugs? A prescription analysis from Finland. Scand J Prim Health Care. 14:1996;54-61.
35. Rotmensch H.H., Mendelevitch L., Silverberg D.S., Liron M. Prescribing pattern of antihypertensive drugs in the community. J Hum Hypertens. 10(Suppl 3):1996;S169-S172.
36. Yusuf S. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation? Circulation. 92:1995;1079-1082.
37. Klungel O.H., Seidell J.C., de Boer A. Assessment of control of hypertension in the population. J Hypertens. 16:1998;395-396.
38. Psaty B.M., Koepsell T.D., Yanez N.D., Smith N.L., Manolio T.A., Heckbert S.R.et al. Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992. An effect of the major clinical trials on clinical practice? JAMA. 273:1995;1436-1438.
39. Psaty B.M., Savage P.J., Tell G.S., Polak J.F., Hirsch C.H., Gardin J.M.et al. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study. JAMA. 270:1993;1837-1841.
40. Schwabe U., Paffrath D. Arzneiverordnungsreport. 1995;Fischer Verlag, Stuttgart.